Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy

Abstract

AbstractCatamenial epilepsy is the best described and most researched sex steroid‐specific seizure exacerbation. Yet despite this there are no current evidence‐based treatments, nor an accepted diagnostic tool. The best tool we currently have is tracking seizures over menstrual cycles; however, the reality of tracking seizures and menstrual cycles is fraught with challenges. In Part 1 of this two‐part review, we outlined the often complex and reciprocal relationship between seizures and sex steroids. An adaptable means of tracking is required. In this review, we outline the extent and limitations of current knowledge on catamenial epilepsy. We use sample data to show how seizure exacerbations can be tracked in short/long and even irregular menstrual cycles. We describe how seizure severity, an often overlooked and underresearched form of catamenial seizure exacerbation, can also be tracked. Finally, given the lack of treatment options for females profoundly affected by catamenial epilepsy, Section 3 focuses on current methods and models for researching sex steroids and seizures as well as limitations and future directions. To permit more informative, mechanism‐focused research in humans, the need for both a consistent classification of catamenial epilepsy and an objective biomarker is highlighted.